| Antibiotic may ease IBS and Doc: Research 'grossly distorted' |
|
|
|
|
An antibiotic widely used to treat diarrhea in travelers may also provide some relief to people with the common and difficult-to-treat condition known as irritable bowel syndrome, according to a pair of new studies in the New England Journal of Medicine.The Food and Drug Administration has not yet approved the antibiotic, rifaximin, for use in IBS, which affects as many as 1 in 5 U.S. adults. The agency is currently reviewing the drug for that purpose and is expected to make a decision in March.In the studies, 1,200 IBS patients took rifaximin or a placebo pill three times a day for two weeks. Roughly 40 percent of the patients who took the antibiotic reported substantial relief from symptoms such as bloating, abdominal pain, and loose stools for at least two weeks during the subsequent month, compared with a little under one-third of the patients taking placebo. All of the patients in the studies had a form of IBS that does not involve constipation. [Read the full article] A now-retracted British study that linked autism to childhood vaccines is an "elaborate fraud," according to a medical journal -- a charge the physician behind the study vigorously denies.The British medical journal BMJ, which published the results of its investigation, concluded Dr. Andrew Wakefield misrepresented or altered the medical histories of all 12 of the patients whose cases formed the basis of the 1998 study -- and that there was "no doubt" Wakefield was responsible. The journalist who wrote the BMJ articles said Thursday he believes Wakefield should face criminal charges. [Read the full article] |








